Inner ear delivery: Challenges and opportunities
- PMID: 32128438
- PMCID: PMC7042639
- DOI: 10.1002/lio2.336
Inner ear delivery: Challenges and opportunities
Abstract
Objectives: The treatment of inner ear disorders remains challenging due to anatomic barriers intrinsic to the bony labyrinth. The purpose of this review is to highlight recent advances and strategies for overcoming these barriers and to discuss promising future avenues for investigation.
Data sources: The databases used were PubMed, EMBASE, and Web of Science.
Results: Although some studies aimed to improve systemic delivery using nanoparticle systems, the majority enhanced local delivery using hydrogels, nanoparticles, and microneedles. Developments in direct intracochlear delivery include intracochlear injection and intracochlear implants.
Conclusions: In the absence of a systemic drug that targets only the inner ear, the best alternative is local delivery that harnesses a combination of new strategies to overcome anatomic barriers. The combination of microneedle technology with hydrogel and nanoparticle delivery is a promising area for future investigation.
Level of evidence: NA.
Keywords: inner ear disorders; intracochlear delivery; microneedles; nanoparticles.
© 2019 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals, Inc. on behalf of The Triological Society.
Conflict of interest statement
Dr Anil K. Lalwani serves on the Medical Advisory Board of Advanced Bionics and on the Surgical Advisory Board of MED‐EL. For the remaining authors, no conflicts of interest were declared.
Figures





References
-
- Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161:S1‐s45. - PubMed
-
- Silverstein H, Lewis WB, Jackson LE, Rosenberg SI, Thompson JH, Hoffmann KK. Changing trends in the surgical treatment of Meniere's disease: results of a 10‐year survey. Ear Nose Throat J. 2003;82:185‐187, 191‐194. - PubMed
-
- Diamond C, O'Connell DA, Hornig JD, Liu R. Systematic review of intratympanic gentamicin in Meniere's disease. J Otolaryngol. 2003;32:351‐361. - PubMed
-
- Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28:1124‐1130. - PubMed
-
- Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's disease. Otol Neurotol. 2003;24:800‐806. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials